Zobrazeno 1 - 10
of 893
pro vyhledávání: '"F Rilke"'
Autor:
J. C. E. Underwood
Publikováno v:
The Journal of Pathology. 160:361-362
Autor:
MA Piris, F Pezzella, JC Martinez-Montero, JL Orradre, R Villuendas, M Sanchez-Beato, R Cuena, MA Cruz, B Martinez, MC Garrido, K Gatter, A Aiello, D Delia, R Giardini, F Rilke
Publikováno v:
British Journal of Cancer
B-cell high-grade lymphomas are heterogeneous in terms of histology, clinical presentation, treatment response and prognosis. As bcl-2 and p53 gene deregulations are frequently involved in several types of lymphoid malignancies, we aimed our investig
Autor:
J.M. Kurtz, J.Y. Petit, F. Rilke, Sven Törnberg, Daniel B. Kopans, M. Tubiana, Virgilio Sacchini, Roland Holland
Publikováno v:
European Journal of Cancer. 30:538-547
INTRODUCTION HIGH QUALITY mammographic screening programmes allow detection of a number of small, non-palpable abnormalities within the breast. Whether benign or malignant, these lesions present problems for radiologists, clinicians and pathologists
Autor:
R. Philipps, E. P. Van Deresch, G. J. Macfarlane, R. S. Pfau, T. E. Larsen, P. A. Hofer, R. A. Cooke, H. Bharucha, A. F. Hood, M. Prade, Patrick Maisonneuve, F. Rilke, Calum S. Muir, A. G. Dempster, J. Nectoux, K. Schafler, K. M. Pozharisski, W. B. Essex, Julian Little, P. Ironside, J. Briggs
Publikováno v:
International Journal of Cancer. 47:483-490
To assess whether the increase in malignant melanoma incidence could be due, at least in part, to changes in histological criteria of malignancy, pathologists in Australia, France, Italy, New Zealand, Norway, Sweden, the United Kingdom, the United St
Autor:
Underwood, J. C. E.
Publikováno v:
Journal of Pathology; 1990, Vol. 160 Issue 4, p361-362, 2p
Autor:
S, Ménard, G, Tomasic, P, Casalini, A, Balsari, S, Pilotti, N, Cascinelli, B, Salvadori, M I, Colnaghi, F, Rilke
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 3(5)
Infiltration by lymphoid cells is a common feature of many human tumors, including breast carcinomas, and the degree of infiltration has been suggested to be a measure of the host immune response. Our analyses in a series of 1919 cases of primary duc
Publikováno v:
The British journal of surgery. 84(1)
Some reports state that infiltrating lobular breast carcinoma (ILC) should not be treated by conservative methods because of a high risk of local recurrence. The aim of this study was to determine whether patients with conservatively treated ILC have
Publikováno v:
Lancet (London, England). 347(9007)
Summary Background The strength of randomised controlled trials (RCTs) is that they allow investigators to draw reliable inferences about treatment differences; physicians can then make a choice between different options. Their weakness is that they
Publikováno v:
Seminars in diagnostic pathology. 12(3)
The concept that poorly differentiated carcinomas (PDC) represent a group in an intermediate position in the spectrum of follicular cell-derived carcinomas of the thyroid gland is currently well established. Because at the well-differentiated end of
Publikováno v:
The Journal of clinical endocrinology and metabolism. 80(1)
By immunocytochemistry and immunoblotting, we examined normal and neoplastic human tissues with polyclonal antibodies raised against selected peptide regions of proprotein convertase-2 and -3 (PC2 and PC3), two proteases that have been shown to selec